ICYMI, a judge has called Genentech's actions in a litigation with Amgen over trastuzumab patents “contrary to the spirit and purpose of the BPCIA." https://t.co/65wx0UmPsD
ICYMI: New research from @JAMA_current looks at characteristics of hospitals that did and did not join #BPCIAdvanced. Learn more: https://t.co/UUaLNAZg8Y https://t.co/IPzb2Qkj0h
